查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球抗菌剂市场评估：依等级、类型、应用、最终用户、地区、机会、预测（2016-2030）
市场调查报告书
商品编码
1355024

全球抗菌剂市场评估：依等级、类型、应用、最终用户、地区、机会、预测（2016-2030）

Antimicrobials Market Assessment, By Grade, By Type, By Applications, By End-user, By Region, Opportunities and Forecast, 2016-2030F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 134 Pages | 商品交期: 3-5个工作天内

价格

全球抗菌剂市场规模预计将从 2022 年的 418.2 亿美元增至 2030 年的 604 亿美元，2023-2030 年预测期间复合年增长率为 4.7%。

生活必需品广泛应用带动市场成长

全球家庭护理产品市场规模从2022年的10,956.3亿美元大幅增长至2023年的11,553.6亿美元，被公认为是一个惊人的成长领域。 为开发可持续且有效的家庭护理产品而对技术创新进行的频繁投资正在为抗菌化合物创造绝佳的机会。 此外，随着抗菌剂在建筑业的广泛使用，市场有机会随着房地产的增加而呈指数级增长。

抗菌□作为抗癌药物彻底改变了医疗领域

根据美国国家卫生统计中心的数据，2022年美国将约有1,918,030名癌症患者被诊断出来，其中大多数癌症患者为男性，达到983,160名。 Iqvia公布的数据显示，2022年全球癌症药物投资预计为1,960亿美元，未来将呈指数级增长。 癌症治疗药物创新的巨大潜力正在为世界各地的抗菌□创造令人难以置信的机会。

新冠肺炎 (COVID-19) 的影响

COVID-19 的爆发对人类产生了前所未有的影响，因为它表明人类很容易受到这种传染病的影响。 由于缺乏关键抗生素，抗菌素抗药性日益威胁整个医疗保健系统在治疗无法治疗的细菌感染方面的作用。 一些传统做法，例如经验性抗菌药物处方和过度消费抗菌卫生用品，对抗菌药物抗药性的流行产生了负面影响。 此次疫情为抗菌药物和疫苗研发的可持续融资搭建了一座桥樑。 为了应对这些挑战，世卫组织及其合作伙伴被忽视疾病药物倡议（DNDi）建立了全球抗生素研发伙伴关係（GARDP），以开发创新的新疗法。 在 COVID-19 大流行期间，全球抗菌药物市场有效成长，促使更多公司致力于解决抗菌药物抗药性问题。

俄罗斯-乌克兰战争的影响

俄罗斯入侵乌克兰不仅造成经济破坏，还造成物质破坏，影响各部门并导致投资不稳定。 俄罗斯的入侵对乌克兰的医疗系统造成了严重影响，导致受伤士兵的细菌感染大幅增加。 来自西方国家的医疗援助在某种程度上稳定了乌克兰目前的局势，这些国家也持续努力对抗战争对乌克兰生活的影响。

本报告研究和分析了全球抗菌剂市场，提供市场规模和预测、市场动态以及主要参与者的现状和前景。

目录

第 1 章研究方法

第 2 章专案范围与定义

第 3 章 COVID-19 对全球抗菌药物市场的影响

第 4 章俄乌战争的影响

第 5 章执行摘要

第 6 章顾客回馈

  • 市场认知度与产品讯息
  • 品牌知名度与忠诚度
  • 购买决策时考虑的因素
  • 购买频率
  • 购买媒介

第 7 章全球抗菌剂市场展望（2016-2030）

  • 市场规模与预测
    • 金额
    • 数量
  • 按年级
    • 食品级
    • 医药级
    • 工业级
  • 依类型
    • 有机
    • 无机
  • 依用途
    • 抗病毒保护
    • 食品包装
    • 抑制细菌生长
    • 其他
  • 按最终用户
    • 居家照护必需品
    • 农业
    • 洗涤剂
    • 纸/纸浆
    • 油墨/黏合剂
    • 医学
    • 个人护理
    • 其他
  • 按地区
    • 北美
    • 欧洲
    • 南美洲
    • 亚太地区
    • 中东/非洲
  • 市占率：依公司划分（2022 年）

第 8 章全球抗菌剂市场展望：按地区划分（2016-2030 年）

  • 北美
    • 市场规模与预测
    • 按年级
    • 依类型
    • 依用途
    • 按最终用户
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 义大利
    • 英国
    • 俄罗斯
    • 荷兰
    • 西班牙
    • 土耳其
    • 波兰
  • 南美洲
    • 巴西
    • 阿根廷
  • 亚太地区
    • 印度
    • 中国
    • 日本
    • 澳大利亚
    • 越南
    • 韩国
    • 印尼
    • 菲律宾
  • 中东/非洲
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 南非

第 9 章供给面分析

  • 生产能力：依公司划分
  • 生产：依公司划分
  • 销售效率：依公司划分
  • 主要工厂地点（最多 25 个）

第 10 章市场地图（2022 年）

  • 按层级
  • 依类型
  • 依用途
  • 按最终用户
  • 按地区

第 11 章宏观环境与产业结构

  • 需求与供给分析
  • 进出口分析 - 数量与价值
  • 供应/价值链分析
  • PESTEL 分析
  • 波特五力分析

第 12 章市场动态

  • 生长促进因素
  • 抑製成长的因素（问题、限制因素）

第 13 章公司主要状况

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 位市场领导者的市场收入分析（2022 年）
  • 併购/合资企业（如果适用）
  • SWOT 分析（针对 5 家进入市场的公司）
  • 专利分析（如果适用）

第 14 章价格分析

第 15 章个案研究

第 16 章主要公司展望

  • Iasis Molecular Science
  • EnBiotix Inc.
  • Armata Pharmaceuticals
  • GlaxoSmithKline
  • Fresenius Kabi Global
  • Destiny Pharma
  • Phico Therapeutics
  • SaNOtize
  • BioVersys
  • Pylum Biosciences

第 17 章策略建议

第 18 章关于我们公司，免责声明

Product Code: MX10476

Global antimicrobials market size was valued at USD 41.82 billion in 2022, expected to reach USD 60.4 billion in 2030, with a CAGR of 4.7% for the forecast period between 2023 and 2030. The discovery of antimicrobials has benefited various sectors progressively with the adopted innovations. The incorporated antimicrobials deliver specific characteristics based on the group they belong to. Specific mechanisms, such as inhibiting protein, cell wall, and nuclei acid synthesis, depolarize the cell membrane and inhibit metabolic pathways in bacteria. Antimicrobial peptides have the potential to impart either antimicrobial or anticancer activities that subsequently disrupt microbial cell membranes by making proper interaction with negatively charged phospholipids. Antimicrobials have extensive involvement in the agri-food sector, which is responsible for imprudent use, and their prominent contribution to resistance can diminish the concerns for health emergencies.

Extensive Application in Daily Essentials Augments Market Growth

Several prominent factors of antimicrobial compounds are responsible for their numerous applications in balancing hygienic-critical environments. Incorporating antimicrobial compounds assists in enhancing the cleanliness and freshness of everyday products by restricting the proliferation of unpleasant mold and mildew. Its essential characteristic is preserving plastic products by inhibiting physical degradation from fungi and bacteria. By minimizing stain and odor-causing bacteria, antimicrobial compounds remain potentially active in imparting laundering properties in fabric care products.

The global home care product market has grown significantly from USD 1,095.63 billion in 2022 to USD 1,155.36 billion in 2023, recognized as a phenomenal rising sector. The frequent investment in innovations to develop sustainable and effective home care products has created impeccable opportunities for antimicrobial compounds. Also, with the huge application of antimicrobials in the construction industry, it has market opportunities to grow exponentially with the rise in real estate.

Regulations Adoption with Antimicrobials Implementation

The numerous benefits of antimicrobial agents can be recognized across various sectors, including health treatments. Despite several advantages, inappropriate usage of antimicrobial agents within healthcare facilities can decisively lead to the acquisition of nosocomial infections, drug toxicity, unwanted resistance build-up, etc. The World Health Organization (WHO) has framed effective regulations on different quantities and combinations for using antimicrobial agents in pharmaceuticals. Fixed doses of antimicrobial combinations can be banned if not approved by national or international guidelines. Stringent legislation has been implemented functionally, regulating the antimicrobials prescribed by qualified healthcare professionals.

Several antimicrobial awareness campaigns, such as World Antibiotic Awareness Week held in November each year by the World Health Organization (WHO) and similar relevant campaigns, are frequently organized to address the benefits of antimicrobials and their consumption in the prescribed form.

Scientifically validated clinical studies have been provided with specific regulations to justify the choice and level of antimicrobial agents to be incorporated in health-related applications. Between November 2021 and February 2022, the regulatory entities and experts from international organizations conducted semi-structured interviews with scientists' regulators for India, Brazil, and South Africa to achieve and improve global and national perspectives on regulatory hurdles and evaluate innovation potential.

Antimicrobials Peptides Incorporated as Anticancer Agents Revolutionizing Healthcare Sector

Structurally described as small cationic or amphipathic molecules, antimicrobial peptides (AMPs) deliver an imperative fundamental defense against bacteria, viruses, and fungi. Several AMPs can target human cancer cells, specifically using their ability to bind the phospholipid phosphatidylserines (PS) that usually appear on the outer leaflet of plasma membranes. Recognized as a significant novel anticancer treatment, AMPs deliver a potential source of effective therapeutic agents and a primary defense against a broad spectrum of pathogens and harmful viruses.

According to the National Center for Health Statistics, the United States diagnosed approximately 1,918,030 cancer cases in 2022, where cancer rate in men was higher with 983,160 cases. Data published by Iqvia reported that the investment in 2022 on global cancer medicines was USD 196 billion, estimated to rise exponentially. The enormous potential for drug innovation in cancer treatment has incredibly generated huge opportunities for antimicrobial peptides globally.

Impact of COVID-19

The outbreak of COVID-19 had an unprecedented impact where the whole of mankind was vulnerable to the infectious disease. Due to the unavailability of significant antibiotics, antimicrobial resistance has successively threatened the entire healthcare system in treating untreatable bacterial infections. Some conventional practices, such as empirical antimicrobial prescription and excessive consumption of antimicrobial hygiene products, negatively impacted the prevalence of antimicrobial resistance. The pandemic significantly accentuated a bridge in sustainable funding across R&Ds of antimicrobial medicines and vaccine innovations. To address such challenges WHO and its partner Drugs for Neglected Diseases initiative (DNDi) progressively built the Global Antibiotic R&D Partnership (GARDP) to develop innovative and novel treatments. During the COVID-19 pandemic, the global market for antimicrobials was growing effectively which encouraged more companies to tackle the conflict of antimicrobial resistance.

Impact of Russia-Ukraine War

The invasion of Russia on Ukraine has led to economic as well as physical devastation that has impacted various sectors leading to instability in sequential investment. In March 2019, the Government of Ukraine has approved the National Action Plan to combat antimicrobial resistance protecting unjustified usage of antimicrobial compounds in applications like livestock, poultry, medicine, crop development, etc. The aggression of Russia has severely impacted Ukraine's healthcare system leading to increase of numerous bacterial infections among the injured soldiers. The medical aid from Western countries has stabilized the prevailing condition to a certain extent where such countries are regularly putting efforts to combat the war impact on the livelihood of Ukraine.

Key Players Landscape and Outlook

To deal with the antimicrobial resistance (AMR) that poses a serious threat to the healthcare systems in an unprecedented way, data reported that, due to hospital infections, an annual financial loss of around USD 13.5 billion occurred in the United States and the European Union. Bioversys is progressively working on innovations to fight antimicrobial resistance. It has prominently developed a diverse antimicrobial agent pipeline that specifically focuses on pathogens targeting gram-positive, gram-negative, and tuberculosis bacteria. Bioversys, on January 2023, has significantly extended the series C round to reach an investment of USD 35.07 million for AMR action, making its first European-based investment.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Impact of COVID-19 on the Global Antimicrobials Market

4. Impact of Russia-Ukraine War

5. Executive Summary

6. Voice of Customer

  • 6.1. Market Awareness and Product Information
  • 6.2. Brand Awareness and Loyalty
  • 6.3. Factors Considered in Purchase Decision
    • 6.3.1. Brand Name
    • 6.3.2. Quality
    • 6.3.3. Quantity
    • 6.3.4. Price
    • 6.3.5. Product Specification
    • 6.3.6. Application Specification
    • 6.3.7. Shelf-life
    • 6.3.8. Availability of Product
  • 6.4. Frequency of Purchase
  • 6.5. Medium of Purchase

7. Global Antimicrobials Market Outlook, 2016-2030F

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
    • 7.1.2. By Volume
  • 7.2. By Grade
    • 7.2.1. Food Grade
    • 7.2.2. Pharma Grade
    • 7.2.3. Industrial Grade
  • 7.3. By Type
    • 7.3.1. Organics
      • 7.3.1.1. Triclosan
      • 7.3.1.2. Quaternary Ammonium Compounds
      • 7.3.1.3. Others
    • 7.3.2. Inorganics
      • 7.3.2.1. Copper
      • 7.3.2.2. Silver
      • 7.3.2.3. Zinc
      • 7.3.2.4. Others
  • 7.4. By Applications
    • 7.4.1. Antiviral Protection
    • 7.4.2. Food Packaging
    • 7.4.3. Bacterial Growth Inhibition
    • 7.4.4. Others
  • 7.5. By End-user
    • 7.5.1. Homecare Essentials
    • 7.5.2. Agriculture
    • 7.5.3. Cleaners & Detergents
    • 7.5.4. Paper & Pulp
    • 7.5.5. Inks & Adhesives
    • 7.5.6. Pharmaceuticals
    • 7.5.7. Personal Care
    • 7.5.8. Others
  • 7.6. By Region
    • 7.6.1. North America
    • 7.6.2. Europe
    • 7.6.3. South America
    • 7.6.4. Asia-Pacific
    • 7.6.5. Middle East and Africa
  • 7.7. By Company Market Share (%), 2022

8. Global Antimicrobials Market Outlook, By Region, 2016-2030F

  • 8.1. North America*
    • 8.1.1. Market Size & Forecast
      • 8.1.1.1. By Value
      • 8.1.1.2. By Volume
    • 8.1.2. By Grade
      • 8.1.2.1. Food Grade
      • 8.1.2.2. Pharma Grade
      • 8.1.2.3. Industrial Grade
    • 8.1.3. By Type
      • 8.1.3.1. Organics
      • 8.1.3.1.1. Triclosan
      • 8.1.3.1.2. Quaternary Ammonium Compounds
      • 8.1.3.1.3. Others
      • 8.1.3.2. Inorganics
      • 8.1.3.2.1. Copper
      • 8.1.3.2.2. Silver
      • 8.1.3.2.3. Zinc
      • 8.1.3.2.4. Others
    • 8.1.4. By Applications
      • 8.1.4.1. Antiviral Protection
      • 8.1.4.2. Food Packaging
      • 8.1.4.3. Bacterial Growth Inhibition
      • 8.1.4.4. Others
    • 8.1.5. By End-user
      • 8.1.5.1. Homecare Essentials
      • 8.1.5.2. Agriculture
      • 8.1.5.3. Cleaners & Detergents
      • 8.1.5.4. Paper & Pulp
      • 8.1.5.5. Inks & Adhesives
      • 8.1.5.6. Pharmaceuticals
      • 8.1.5.7. Personal Care
      • 8.1.5.8. Others
    • 8.1.6. United States*
      • 8.1.6.1. Market Size & Forecast
      • 8.1.6.1.1. By Value
      • 8.1.6.1.2. By Volume
      • 8.1.6.2. By Grade
      • 8.1.6.2.1. Food Grade
      • 8.1.6.2.2. Pharma Grade
      • 8.1.6.2.3. Industrial Grade
      • 8.1.6.3. By Type
      • 8.1.6.3.1. Organics
      • 8.1.6.3.1.1. Triclosan
      • 8.1.6.3.1.2. Quaternary Ammonium Compounds
      • 8.1.6.3.1.3. Others
      • 8.1.6.3.2. Inorganics
      • 8.1.6.3.2.1. Copper
      • 8.1.6.3.2.2. Silver
      • 8.1.6.3.2.3. Zinc
      • 8.1.6.3.2.4. Others
      • 8.1.6.4. By Applications
      • 8.1.6.4.1. Antiviral Protection
      • 8.1.6.4.2. Food Packaging
      • 8.1.6.4.3. Bacterial Growth Inhibition
      • 8.1.6.4.4. Others
      • 8.1.6.5. By End-user
      • 8.1.6.5.1. Homecare Essentials
      • 8.1.6.5.2. Agriculture
      • 8.1.6.5.3. Cleaners & Detergents
      • 8.1.6.5.4. Paper & Pulp
      • 8.1.6.5.5. Inks & Adhesives
      • 8.1.6.5.6. Pharmaceuticals
      • 8.1.6.5.7. Personal Care
      • 8.1.6.5.8. Others
    • 8.1.7. Canada
    • 8.1.8. Mexico

All segments will be provided for all regions and countries covered

  • 8.2. Europe
    • 8.2.1. Germany
    • 8.2.2. France
    • 8.2.3. Italy
    • 8.2.4. United Kingdom
    • 8.2.5. Russia
    • 8.2.6. Netherlands
    • 8.2.7. Spain
    • 8.2.8. Turkey
    • 8.2.9. Poland
  • 8.3. South America
    • 8.3.1. Brazil
    • 8.3.2. Argentina
  • 8.4. Asia-Pacific
    • 8.4.1. India
    • 8.4.2. China
    • 8.4.3. Japan
    • 8.4.4. Australia
    • 8.4.5. Vietnam
    • 8.4.6. South Korea
    • 8.4.7. Indonesia
    • 8.4.8. Philippines
  • 8.5. Middle East & Africa
    • 8.5.1. Saudi Arabia
    • 8.5.2. UAE
    • 8.5.3. South Africa

9. Supply Side Analysis

  • 9.1. Capacity, By Company
  • 9.2. Production, By Company
  • 9.3. Operating Efficiency, By Company
  • 9.4. Key Plant Locations (Up to 25)

10. Market Mapping, 2022

  • 10.1. By Grade
  • 10.2. By Type
  • 10.3. By Application
  • 10.4. By End-user
  • 10.5. By Region

11. Macro Environment and Industry Structure

  • 11.1. Supply Demand Analysis
  • 11.2. Import Export Analysis - Volume and Value
  • 11.3. Supply/Value Chain Analysis
  • 11.4. PESTEL Analysis
    • 11.4.1. Political Factors
    • 11.4.2. Economic System
    • 11.4.3. Social Implications
    • 11.4.4. Technological Advancements
    • 11.4.5. Environmental Impacts
    • 11.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
  • 11.5. Porter's Five Forces Analysis
    • 11.5.1. Supplier Power
    • 11.5.2. Buyer Power
    • 11.5.3. Substitution Threat
    • 11.5.4. Threat from New Entrant
    • 11.5.5. Competitive Rivalry

12. Market Dynamics

  • 12.1. Growth Drivers
  • 12.2. Growth Inhibitors (Challenges, Restraints)

13. Key Players Landscape

  • 13.1. Competition Matrix of Top Five Market Leaders
  • 13.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2022)
  • 13.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
  • 13.4. SWOT Analysis (For Five Market Players)
  • 13.5. Patent Analysis (If Applicable)

14. Pricing Analysis

15. Case Studies

16. Key Players Outlook

  • 16.1. Iasis Molecular Science¬¬¬¬¬¬¬
    • 16.1.1. Company Details
    • 16.1.2. Key Management Personnel
    • 16.1.3. Products & Services
    • 16.1.4. Financials (As reported)
    • 16.1.5. Key Market Focus & Geographical Presence
    • 16.1.6. Recent Developments
  • 16.2. EnBiotix Inc.
  • 16.3. Armata Pharmaceuticals
  • 16.4. GlaxoSmithKline
  • 16.5. Fresenius Kabi Global
  • 16.6. Destiny Pharma
  • 16.7. Phico Therapeutics
  • 16.8. SaNOtize
  • 16.9. BioVersys
  • 16.10. Pylum Biosciences

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work

17. Strategic Recommendations

18. About Us & Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 2. Global Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 3. Global Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 4. Global Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 5. Global Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 6. Global Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 7. Global Antimicrobials Market Share, By Region, In USD Billion, 2016-2030F
  • Figure 8. North America Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 9. North America Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 10. North America Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 11. North America Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 12. North America Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 13. North America Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 14. North America Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 15. United States Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 16. United States Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 17. United States Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 18. United States Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 19. United States Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 20. United States Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 21. Canada Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 22. Canada Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 23. Canada Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 24. Canada Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 25. Canada Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 26. Canada Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 27. Mexico Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 28. Mexico Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 29. Mexico Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 30. Mexico Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 31. Mexico Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 32. Mexico Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 33. Europe Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 34. Europe Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 35. Europe Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 36. Europe Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 37. Europe Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 38. Europe Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 39. Europe Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 40. Germany Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 41. Germany Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 42. Germany Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 43. Germany Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 44. Germany Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 45. Germany Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 46. France Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 47. France Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 48. France Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 49. France Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 50. France Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 51. France Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 52. Italy Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 53. Italy Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 54. Italy Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 55. Italy Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 56. Italy Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 57. Italy Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 58. United Kingdom Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 59. United Kingdom Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 60. United Kingdom Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 61. United Kingdom Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 62. United Kingdom Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 63. United Kingdom Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 64. Russia Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 65. Russia Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 66. Russia Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 67. Russia Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 68. Russia Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 69. Russia Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 70. Netherlands Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 71. Netherlands Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 72. Netherlands Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 73. Netherlands Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 74. Netherlands Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 75. Netherlands Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 76. Spain Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 77. Spain Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 78. Spain Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 79. Spain Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 80. Spain Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 81. Spain Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 82. Turkey Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 83. Turkey Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 84. Turkey Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 85. Turkey Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 86. Turkey Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 87. Turkey Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 88. Poland Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 89. Poland Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 90. Poland Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 91. Poland Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 92. Poland Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 93. Poland Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 94. South America Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 95. South America Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 96. South America Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 97. South America Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 98. South America Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 99. South America Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 100. South America Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 101. Brazil Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 102. Brazil Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 103. Brazil Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 104. Brazil Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 105. Brazil Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 106. Brazil Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 107. Argentina Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 108. Argentina Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 109. Argentina Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 110. Argentina Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 111. Argentina Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 112. Argentina Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 113. Asia-Pacific Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 114. Asia-Pacific Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 115. Asia-Pacific Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 116. Asia-Pacific Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 117. Asia-Pacific Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 118. Asia- Pacific Cream Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 119. Asia-Pacific Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 120. India Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 121. India Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 122. India Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 123. India Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 124. India Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 125. India Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 126. China Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 127. China Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 128. China Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 129. China Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 130. China Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 131. China Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 132. Japan Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 133. Japan Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 134. Japan Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 135. Japan Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 136. Japan Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 137. Japan Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 138. Australia Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 139. Australia Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 140. Australia Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 141. Australia Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 142. Australia Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 143. Australia Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 144. Vietnam Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 145. Vietnam Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 146. Vietnam Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 147. Vietnam Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 148. Vietnam Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 149. Vietnam Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 150. South Korea Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 151. South Korea Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 152. South Korea Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 153. South Korea Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 154. South Korea Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 155. South Korea Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 156. Indonesia Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 157. Indonesia Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 158. Indonesia Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 159. Indonesia Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 160. Indonesia Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 161. Indonesia Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 162. Philippines Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 163. Philippines Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 164. Philippines Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 165. Philippines Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 166. Philippines Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 167. Philippines Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 168. Middle East & Africa Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 169. Middle East & Africa Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 170. Middle East & Africa Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 171. Middle East & Africa Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 172. Middle East & Africa Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 173. Middle East & Africa Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 174. Middle East & Africa Antimicrobials Market Share, By Country, In USD Billion, 2016-2030F
  • Figure 175. Saudi Arabia Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 176. Saudi Arabia Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 177. Saudi Arabia Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 178. Saudi Arabia Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 179. Saudi Arabia Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 180. Saudi Arabia Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 181. UAE Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 182. UAE Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 183. UAE Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 184. UAE Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 185. UAE Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 186. UAE Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 187. South Africa Antimicrobials Market, By Value, In USD Billion, 2016-2030F
  • Figure 188. South Africa Antimicrobials Market, By Volume, In Kilotons, 2016-2030F
  • Figure 189. South Africa Antimicrobials Market Share, By Grade, In USD Billion, 2016-2030F
  • Figure 190. South Africa Antimicrobials Market Share, By Type, In USD Billion, 2016-2030F
  • Figure 191. South Africa Antimicrobials Market Share, By Applications, In USD Billion, 2016-2030F
  • Figure 192. South Africa Antimicrobials Market Share, By End-user Industry, In USD Billion, 2016-2030F
  • Figure 193. By Grade Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 194. By Type Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 195. By Applications Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 196. By End-user Industry Map-Market Size (USD Billion) & Growth Rate (%), 2022
  • Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2022